Selected Publications

  1. Ahlstedt J, Johansson E, Sydoff M, Karlsson H, Thordarsson E, Gram M, Eriksson O: Non-invasive imaging methodologies for assessment of radiation damage to bone marrow and kidneys from peptide receptor radionuclide therapy. Neuroendocrinology 2019.
  2. Albrecht DS, Forsberg A, Sandström A, Bergan C, Kadetoff D, Protsenko E, Lampa J, Lee YC, Höglund CO, Catana C: Brain glial activation in fibromyalgia–A multi-site positron emission tomography investigation. Brain, behavior, and immunity 2019, 75:72-83.
  3. Avendaño-Estrada A, Velasco-Campos F, Carrillo-Ruiz J, Ávila-Rodríguez M: On the use of quantitative PET imaging to study human brain in healthy controls and epileptic patients: A 18FGD and 18FMMZ study. In: AIP Conference Proceedings: 2019: AIP Publishing; 2019: 030001.
  4. Bailey JJ, Kaiser L, Lindner S, Wüst M, Thiel A, Soucy J-P, Rosa-Neto P, Scott PJ, Unterrainer M, Kaplan DR: First-in-Human Brain Imaging of [18F] TRACK, a PET tracer for Tropomyosin Receptor Kinases. ACS chemical neuroscience 2019.
  5. Baldinger-Melich P, Gryglewski G, Philippe C, James GM, Vraka C, Silberbauer L, Balber T, Vanicek T, Pichler V, Unterholzner J: The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography. Brain stimulation 2019.
  6. Bascuñana P, García-García L, Javela J, de la Rosa RF, Shiha AA, Kelly J, Delgado M, Pozo MÁ: PET Neuroimaging Reveals Serotonergic and Metabolic Dysfunctions in the Hippocampal Electrical Kindling Model of Epileptogenesis. Neuroscience 2019, 409:101-110.
  7. Bascuñana P, Thackeray JT, Bankstahl M, Bengel FM, Bankstahl JP: Anesthesia and Preconditioning Induced Changes in Mouse Brain [18 F] FDG Uptake and Kinetics. Molecular Imaging and Biology 2019:1-8.
  8. Bauman MD, Lesh TA, Rowland DJ, Schumann CM, Smucny J, Kukis DL, Cherry SR, McAllister AK, Carter CS: Preliminary evidence of increased striatal dopamine in a nonhuman primate model of maternal immune activation. Translational psychiatry 2019, 9(1):135.
  9. Benz DC, Ferro P, Safa N, Messerli M, von Felten E, Huang W, Patriki D, Giannopoulos AA, Fuchs TA, Gräni C: Role of quantitative myocardial blood flow and 13 N-ammonia washout for viability assessment in ischemic cardiomyopathy. Journal of Nuclear Cardiology 2019:1-11.
  10. Benz DC, Gräni C, Ferro P, Neumeier L, Messerli M, Possner M, Clerc OF, Gebhard C, Gaemperli O, Pazhenkottil AP: Corrected coronary opacification decrease from coronary computed tomography angiography: validation with quantitative 13N-ammonia positron emission tomography. Journal of Nuclear Cardiology 2019, 26(2):561-568.
  11. Berroterán-Infante N, Kalina T, Fetty L, Janisch V, Velasco R, Vraka C, Hacker M, Haug AR, Pallitsch K, Wadsak W: (R)-[18F] NEBIFQUINIDE: A promising new PET tracer for TSPO imaging. European journal of medicinal chemistry 2019.
  12. Billington S, Shoner S, Lee S, Clark‐Snustad K, Pennington M, Lewis D, Muzi M, Rene S, Lee J, Nguyen TB: PET Imaging of [11C] Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporine A. Clinical Pharmacology & Therapeutics 2019.
  13. Bolaños-Puchet S: xgrid3d: A free software tool for quantitative image analysis and internal dosimetry. In: AIP Conference Proceedings: 2019: AIP Publishing; 2019: 030003.
  14. Brugnolo A, De Carli F, Pagani M, Morbelli S, Jonsson C, Chincarini A, Frisoni GB, Galluzzi S, Perneczky R, Drzezga A: Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer’s Disease. Journal of Alzheimer’s Disease 2019(Preprint):1-12.
  15. Brumberg J, Tran-Gia J, Lapa C, Isaias IU, Samnick S: PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time. Annals of nuclear medicine 2019, 33(2):69-77.
  16. Buchert R, Lange C, Spehl TS, Apostolova I, Frings L, Jonsson C, Meyer PT, Hellwig S: Diagnostic performance of the specific uptake size index for semi-quantitative analysis of I-123-FP-CIT SPECT: harmonized multi-center research setting versus typical clinical single-camera setting. EJNMMI research 2019, 9(1):37.
  17. Buchsbaum MS, DeCastro A: Positron Emission Tomography and Computed Tomography Measurement of Brown Fat Thermal Activation: Key Tool for Developing Novel Pharmacotherapeutics for Obesity and Diabetes. In: Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. edn.: Springer, Cham; 2019: 191-210.
  18. Burley TA, Da Pieve C, Martins CD, Ciobota DM, Allott L, Oyen WJ, Harrington KJ, Smith G, Kramer-Marek G: Affibody-based PET imaging to guide EGFR-targeted cancer therapy in head and neck squamous cell cancer models. Journal of Nuclear Medicine 2019, 60(3):353-361.
  19. Büther F, Seifert R, Backhaus P, Schäfers M: Einfluss der Detektorsensitivität eines Blutsamplers auf die kinetische Modellierung von PET-Daten: Ergebnisse einer numerischen Simulationsstudie. Nuklearmedizin 2019, 58(02):P114.
  20. Cao Q, Huang Q, Mohan C, Li C: μPET/CT imaging of local and systemic immune response using 64Cu-αCD11b. Journal of Nuclear Medicine 2019:jnumed. 118.220350.
  21. Cao Y, Gathaiya N, Han Q, Kemp BJ, Jensen MD: Subcutaneous Adipose Tissue Free Fatty Acid Uptake Measured Using Positron Emission Tomography and Adipose Biopsies in Humans. American Journal of Physiology-Endocrinology and Metabolism 2019.
  22. Castaño-Castaño S, Feijoo-Cuaresma M, Paredes-Pacheco J, Morales-Navas M, Ruiz-Guijarro J, Sanchez-Santed F, Nieto-Escámez F: tDCS RECOVERS DEPTH PERCEPTION IN ADULT AMBLYOPIC RATS AND REORGANIZES VISUAL CORTEX ACTIVITY. Behavioural brain research 2019:111941.
  23. Castellano C-A, Hudon C, Croteau E, Fortier M, St-Pierre V, Vandenberghe C, Nugent S, Tremblay S, Paquet N, Lepage M: Links Between Metabolic and Structural Changes in the Brain of Cognitively Normal Older Adults: A 4-Year Longitudinal Follow-Up. Frontiers in aging neuroscience 2019, 11.
  24. Ceccarini J, Ahmad R, Van de Vliet L, Casteels C, Vandenbulcke M, Vandenberghe W, Van Laere K: Behavioral symptoms in premanifest Huntington disease correlate with reduced frontal CB1R levels. Journal of Nuclear Medicine 2019, 60(1):115-121.
  25. Chang Y-J, Ho C-L, Cheng K-H, Kuo W-I, Lee W-C, Lan K-L, Chang C-H: Biodistribution, pharmacokinetics and radioimmunotherapy of 188 Re-cetuximab in NCI-H292 human lung tumor-bearing nude mice. Investigational new drugs 2019:1-12.
  26. Chen Y-H, Chang K-P, Chu S-C, Yen T-C, Wang L-Y, Chang JT-C, Hsu C-L, Ng S-H, Liu S-H, Chan S-C: Value of early evaluation of treatment response using 18 F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma. European journal of nuclear medicine and molecular imaging 2019, 46(3):650-660.
  27. Cheng M-F, Huang Y-Y, Ho B-Y, Kuo T-C, Hsin L-W, Shiue C-Y, Kuo H-C, Jeng Y-M, Yen R-F, Tien Y-W: Prospective comparison of (4S)-4-(3-18 F-fluoropropyl)-l-glutamate versus 18 F-fluorodeoxyglucose PET/CT for detecting metastases from pancreatic ductal adenocarcinoma: a proof-of-concept study. European journal of nuclear medicine and molecular imaging 2019:1-11.
  28. Chung Y-H, Yu C-F, Chiu S-C, Chiu H, Hsu S-T, Wu C-R, Yang C-L, Hong J-H, Yen T-C, Chen F-H: Diffusion-weighted MRI and 18 F-FDG PET correlation with immunity in early radiotherapy response in BNL hepatocellular carcinoma mouse model: timeline validation. European journal of nuclear medicine and molecular imaging 2019:1-12.
  29. da Cunha-Bang S, Ettrup A, Mc Mahon B, Skibsted AP, Schain M, Lehel S, Dyssegaard A, Jørgensen LM, Møller K, Gillings N: Measuring endogenous changes in serotonergic neurotransmission with [11 C] Cimbi-36 positron emission tomography in humans. Translational psychiatry 2019, 9(1):134.
  30. Dagnino APA, da Silva RBM, Chagastelles PC, Pereira TCB, Venturin GT, Greggio S, da Costa JC, Bogo MR, Campos MM: Nociceptin/orphanin FQ receptor modulates painful and fatigue symptoms in a mouse model of fibromyalgia. Pain 2019, 160(6):1383-1401.
  31. Dahlsson Leitao C, Rinne SS, Mitran B, Vorobyeva A, Andersson KG, Tolmachev V, Ståhl S, Löfblom J, Orlova A: Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers. International journal of molecular sciences 2019, 20(5):1080.
  32. De Bruycker S, Vangestel C, Van den Wyngaert T, Pauwels P, Staelens S, Stroobants S: 18F-flortanidazole hypoxia PET holds promise as a prognostic and predictive imaging biomarker in a lung cancer xenograft model treated with metformin and radiotherapy. Journal of Nuclear Medicine 2019, 60(1):34-40.
  33. De Carli F, Nobili F, Pagani M, Bauckneht M, Massa F, Grazzini M, Jonsson C, Peira E, Morbelli S, Arnaldi D: Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease. European journal of nuclear medicine and molecular imaging 2019, 46(2):334-347.
  34. De Lombaerde S, Neyt S, Vanhove C, De Vos F: In Vivo Measurement of Hepatic Drug Transporter Inhibition with Radiolabeled Bile Acids. In: Experimental Cholestasis Research. edn.: Springer; 2019: 87-98.
  35. de Souza GS, da Silva AMM: Investigation of Time-Activity Curve Behavior in Dynamic [11 C]-(R)-PK11195 PET in Cortical Brain Regions: Preliminary Results. In: World Congress on Medical Physics and Biomedical Engineering 2018: 2019: Springer; 2019: 699-702.
  36. de Souza GS, da Silva AMM: Investigation of Time-Activity Curve Behavior in Dynamic [11 C]-(R)-PK11195 PET in Cortical Brain Regions: Preliminary Results. In: World Congress on Medical Physics and Biomedical Engineering 2018: 2019: Springer; 2019: 699-702.
  37. Drescher R, Gühne F, Seifert P, Kühnel C, Freesmeyer M: Ex Vivo Evaluation of Residual Activity and Infusion Dynamics in a Commercially Available Yttrium-90 Resin Microsphere Administration System. Journal of Vascular and Interventional Radiology 2019.
  38. Ebert SE, Jensen P, Ozenne B, Armand S, Svarer C, Stenbaek DS, Moeller K, Dyssegaard A, Thomsen G, Steinmetz J: Molecular imaging of neuroinflammation in patients after mild traumatic brain injury: a longitudinal 123I‐CLINDE SPECT study. European journal of neurology 2019.
  39. Endo H, Shimada H, Sahara N, Ono M, Koga S, Kitamura S, Niwa F, Hirano S, Kimura Y, Ichise M: In vivo binding of a tau imaging probe,[11C] PBB3, in patients with progressive supranuclear palsy. Movement Disorders 2019.
  40. Erdmann S, Niederstadt L, Koziolek EJ, Gómez JDC, Prasad S, Wagener A, von Hacht JL, Hallmann S, Exner S, Bandholtz S: CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer. bioRxiv 2019:575902.
  41. Eriksen PL, Thomsen KL, Larsen LP, Grønbæk H, Vilstrup H, Sørensen M: Non‐alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver–a human galactose positron emission tomography study. Alimentary pharmacology & therapeutics 2019.
  42. Espes D, Manell E, Rydén A, Carlbom L, Weis J, Jensen-Waern M, Jansson L, Eriksson O: Pancreatic perfusion and its response to glucose as measured by simultaneous PET/MRI. Acta diabetologica 2019:1-8.
  43. Ezura M, Kikuchi A, Ishiki A, Okamura N, Hasegawa T, Harada R, Watanuki S, Funaki Y, Hiraoka K, Baba T: Longitudinal changes in 18F‐THK 5351 positron emission tomography in corticobasal syndrome. European journal of neurology 2019.
  44. Fiechter M, Roggo A, Burger IA, Bengs S, Treyer V, Becker A, Marȩdziak M, Haider A, Portmann A, Messerli M: Association between resting amygdalar activity and abnormal cardiac function in women and men: a retrospective cohort study. European Heart Journal-Cardiovascular Imaging 2019, 20(6):625-632.
  45. Fortier M, Castellano C-A, Croteau E, Langlois F, Bocti C, St-Pierre V, Vandenberghe C, Bernier M, Roy M, Descoteaux M: A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment. Alzheimer’s & Dementia 2019, 15(5):625-634.
  46. Freesmeyer M, Winkens T, Kühnel C, Opfermann T, Seifert P: Technetium-99m SPECT/US Hybrid Imaging Compared with Conventional Diagnostic Thyroid Imaging with Scintigraphy and Ultrasound. Ultrasound in medicine & biology 2019.
  47. Fukai M, Bunai T, Hirosawa T, Kikuchi M, Ito S, Minabe Y, Ouchi Y: Endogenous dopamine release under transcranial direct-current stimulation governs enhanced attention: a study with positron emission tomography. Translational psychiatry 2019, 9(1):115.
  48. Geisler S, Stegmayr C, Niemietz N, Lohmann P, Rapp M, Stoffels G, Willuweit A, Galldiks N, Filss CP, Sabel M: Treatment-related uptake of O-(2-[18F] fluoroethyl)-L-tyrosine and L-[methyl-3H]-methionine after tumor resection in rat glioma models. Journal of Nuclear Medicine 2019:jnumed. 119.225680.
  49. Gerke BA, Yamashita AL, Sigua-Rodriguez EA, Olate S, Iwaki LCV, Iwaki-Filho L: Análisis Descriptivo y Cualitativo de Tres Software Gratuitos Usados para la Conversión de Formato DICOM para STL. International journal of odontostomatology 2019, 13(1):103-111.
  50. Ghotbi AA, Clemmensen A, Kyhl K, Follin B, Hasbak P, Engstrøm T, Ripa RS, Kjaer A: Rubidium-82 PET imaging is feasible in a rat myocardial infarction model. Journal of Nuclear Cardiology 2019, 26(3):798-809.
  51. Giridharan VV, Barichello T, Selvaraj S: Molecular Imaging of Blood–Brain Barrier Permeability in Preclinical Models Using PET and SPECT. In: Blood-Brain Barrier. edn.: Springer; 2019: 329-342.
  52. Glud AN, Jakobsen S, Landau AM, Alstrup AKO, Sørensen JCH: Visualization of intrathecal delivery by PET-imaging. Journal of neuroscience methods 2019, 317:45-48.
  53. González Mancebo D, Becerro AI, Corral A, Moros M, Balcerzyk M, Fuente JsMdl, Ocaña M: Enhancing Luminescence and X-ray Absorption Capacity of Eu3+: LaF3 Nanoparticles by Bi3+ Codoping. ACS Omega 2019, 4(1):765-774.
  54. Guberina M, Eberhardt W, Stuschke M, Gauler T, Aigner C, Schuler M, Stamatis G, Theegarten D, Jentzen W, Herrmann K: Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial. European journal of nuclear medicine and molecular imaging 2019:1-9.
  55. Guenthoer P, Fuchs K, Reischl G, Quintanilla-Martinez L, Gonzalez-Menendez I, Laufer S, Pichler BJ, Kneilling M: Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritis. Inflammopharmacology 2019:1-11.
  56. Haider A, Bengs S, Maredziak M, Messerli M, Fiechter M, Giannopoulos AA, Treyer V, Schwyzer M, Kamani CH, Patriki D: Heart rate reserve during pharmacological stress is a significant negative predictor of impaired coronary flow reserve in women. European journal of nuclear medicine and molecular imaging 2019:1-11.
  57. Haider A, Herder AM, Krämer SD, Varisco J, Keller C, Frauenknecht K, Auberson YP, Temme L, Robaa D, Sippl W: Preclinical Evaluation of Benzazepine-Based PET Radioligands (R)-and (S)-11C-Me-NB1 Reveals Distinct Enantiomeric Binding Patterns and Tightrope Walk between GluN2B-and Sigma1 Receptor-Targeted PET Imaging. Journal of Nuclear Medicine 2019:jnumed. 118.221051.
  58. Hammoud DA, Sinharay S, Shah S, Schreiber-Stainthorp W, Maric D, Muthusamy S, Lee DE, Lee CA, Basuli F, Reid WC: Neuroinflammatory Changes in Relation to Cerebrospinal Fluid Viral Load in Simian Immunodeficiency Virus Encephalitis. mBio 2019, 10(3):e00970-00919.
  59. Hatashita S, Wakebe D: Amyloid β deposition and glucose metabolism on the long-term progression of preclinical Alzheimer’s disease. Future science OA 2019, 5(3):FSO356.
  60. Hattori Y, Aoyama K, Maeda J, Arimura N, Takahashi Y, Sasaki M, Fujinaga M, Seki C, Nagai Y, Kawamura K: Design, synthesis, and evaluation of (4R)-1-{3-[2-(18F) fluoro-4-methylpyridin-3-yl] phenyl}-4-[4-(1, 3-thiazol-2-ylcarbonyl) piperazin-1-yl] pyrrolidin-2-one ([18F] T-401) as a novel positron-emission tomography imaging agent for monoacylglycerol lipase. Journal of medicinal chemistry 2019.
  61. Hauser T-K, Seeger A, Bender B, Klose U, Thurow J, Ernemann U, Tatagiba M, Meyer PT, Khan N, Roder C: Hypercapnic BOLD MRI compared to H215O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease. NeuroImage: Clinical 2019, 22:101713.
  62. Hayer S, Zeilinger M, Weiss V, Dumanic M, Seibt M, Niederreiter B, Shvets T, Pichler F, Wadsak W, Podesser BK: Multimodal [18F] FDG PET/CT is a direct readout for inflammatory bone repair: a longitudinal study in TNFα transgenic mice. Journal of Bone and Mineral Research 2019.
  63. Herde AM, Mihov Y, Krämer SD, Mu L, Adamantidis A, Ametamey SM, Hasler G: Chronic Nicotine Exposure Alters Metabotropic Glutamate Receptor 5: Longitudinal PET Study and Behavioural Assessment in Rats. Neurotoxicity research 2019:1-11.
  64. Hobson BA, Rowland DJ, Sisó S, Guignet MA, Harmany ZT, Bandara S, Saito N, Harvey DJ, Bruun DA, Garbow JR: TSPO PET Using [18F] PBR111 Reveals Persistent Neuroinflammation Following Acute Diisopropylfluorophosphate Intoxication in the Rat. Toxicological Sciences 2019.
  65. Hofheinz F, Maus J, Zschaeck S, Rogasch J, Schramm G, Oehme L, Apostolova I, Kotzerke J, van den Hoff J: Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET. EJNMMI research 2019, 9(1):23.
  66. Horakova O, Kroupova P, Bardova K, Buresova J, Janovska P, Kopecky J, Rossmeisl M: Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport. Scientific reports 2019, 9(1):6156.
  67. Huang C-Y, Hsiao T, Lin K-J, Huang K-L, Fung H-C, Liu C-H, Chang T-Y, Weng Y-C, Hsu W-C, Yen T-C: Amyloid PET pattern with dementia and amyloid angiopathy in Taiwan familial AD with D678H APP mutation. Journal of the neurological sciences 2019, 398:107-116.
  68. Hulpia F, Verhoeven J, Van Calenbergh S, De Vos F, Kersemans K, Bolcaen J, Goeman J, De Lombaerde S, Descamps B, Hallaert G: New Quick And Easy Publication-Will be edited by Biblio team. Quick And Easy Journal Title 2019.
  69. Isaac-Olivé K, Ocampo-García BE, Aranda-Lara L, Santos-Cuevas CL, Jiménez-Mancilla NP, Luna-Gutiérrez MA, Medina LA, Nagarajan B, Sabnis N, Raut S: [99m Tc-HYNIC-N-dodecylamide]: a new hydrophobic tracer for labelling reconstituted high-density lipoproteins (rHDL) for radioimaging. Nanoscale 2019, 11(2):541-551.
  70. Ishibashi K, Miura Y, Toyohara J, Ishiwata K, Ishii K: Unchanged type 1 metabotropic glutamate receptor availability in patients with Alzheimer’s disease: A study using 11C-ITMM positron emission tomography. NeuroImage: Clinical 2019:101783.
  71. Jacob A, Ma Y, Nasiri E, Ochani M, Carrion J, Peng S, Brenner M, Huerta PT, Wang P: Extracellular cold inducible RNA-binding protein mediates binge alcohol-induced brain hypoactivity and impaired cognition in mice. Molecular Medicine 2019, 25(1):24.
  72. Johnson TB, Brudvig JJ, Lehtimäki KK, Cain JT, White KA, Bragge T, Rytkönen J, Huhtala T, Timm D, Vihma M: A multimodal approach to identify clinically relevant parameters to monitor disease progression in a preclinical model of neuropediatric disease. bioRxiv 2019:522011.
  73. Kaeopookum P, Summer D, Pfister J, Orasch T, Lechner BE, Petrik M, Novy Z, Matuszczak B, Rangger C, Haas H: Modifying the Siderophore Triacetylfusarinine C for Molecular Imaging of Fungal Infection. Molecular Imaging and Biology 2019:1-10.
  74. Kanda A, Kondo K, Hosaka N, Kobayashi Y, Bui DV, Yun Y, Suzuki K, Sawada S, Asako M, Nakamura A: Eosinophilic Upper Airway Inflammation in a Murine Model Using an Adoptive Transfer System Induces Hyposmia and Epithelial Layer Injury with Convex Lesions. Medical Sciences 2019, 7(2):22.
  75. Kazuya M, Ohnishi A, Sasaki M, Ikari Y, Aita K, Watanabe Y, Kusuhara H, Sugiyama Y, Senda M: Quantitative investigation of hepatobiliary transport of [11C] telmisartan in humans by PET imaging. Drug Metabolism and Pharmacokinetics 2019.
  76. Kim J, Choi K-H, Cho S-G, Kang S-R, Yoo SW, Kwon SY, Min J-J, Bom H-S, Song H-C: Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects. Scientific reports 2019, 9(1):949.
  77. Kim J, Ghadery C, Cho SS, Mihaescu A, Christopher L, Valli M, Houle S, Strafella AP: Network Patterns of Beta-Amyloid Deposition in Parkinson’s Disease. Molecular neurobiology 2019:1-10.
  78. Kim MJ, Lee C-H, Lee Y, Youn H, Kang KW, Kwon J, Alavi A, Carlin S, Cheon GJ, Chung J-K: Glucose-6-phosphatase Expression–Mediated [18 F] FDG Efflux in Murine Inflammation and Cancer Models. Molecular Imaging and Biology 2019:1-9.
  79. Kircher M, Ihne S, Brumberg J, Morbach C, Knop S, Kortüm KM, Störk S, Buck AK, Reiter T, Bauer WR: Detection of cardiac amyloidosis with 18 F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy. European journal of nuclear medicine and molecular imaging 2019:1-10.
  80. Kolb H, Barret O, Bhattacharya A, Chen G, Constantinescu C, Huang C, Letavic M, Tamagnan G, Xia C, Zhang W: Preclinical evaluation and non-human primate receptor occupancy study of 18F-JNJ-64413739, a novel PET radioligand for P2X7 receptors. Journal of Nuclear Medicine 2019:jnumed. 118.212696.
  81. Lane N, Nyman J, Uppuganti S, Chaudhari A, Aguirre J, Shidara K, Liu X, Yao W, Kimmel D: Inhibition of vascular endothelial growth factor in young adult mice causes low bone blood flow and bone strength with no effect on bone mass in trabecular regions. Bone Reports 2019:100210.
  82. Lavisse S, Williams S, Lecourtois S, van Camp N, Guillermier M, Gipchtein P, Jan C, Goutal S, Eymin L, Valette J: Longitudinal characterization of cognitive and motor deficits in an excitotoxic lesion model of striatal dysfunction in non-human primates. Neurobiology of disease 2019:104484.
  83. Lee JW, Song YS, Kim H, Ku BD, Lee WW: Alteration of tremor dominant and postural instability gait difficulty subtypes during the progression of Parkinson’s disease: analysis of the PPMI cohort. Frontiers in neurology 2019, 10:471.
  84. Lehner E, Gündel D, Liebau A, Plontke S, Mäder K: Intracochlear PLGA based implants for dexamethasone release: challenges and solutions. International Journal of Pharmaceutics: X 2019:100015.
  85. Leuzy A, Cicognola C, Chiotis K, Saint-Aubert L, Lemoine L, Andreasen N, Zetterberg H, Ye K, Blennow K, Höglund K: Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease. European journal of nuclear medicine and molecular imaging 2019:1-12.
  86. LEVY CdS, COSTA FGdB, FARIA DdP, STEFANO JT, COGLIATI B, OLIVEIRA CP: 18F-FDG PET/CT as an assessment tool of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease development in experimental model. Arquivos de gastroenterologia 2019(AHEAD).
  87. Lin PY, Chen KH, Miao YB, Chen HL, Lin KJ, Chen CT, Yeh CN, Chang Y, Sung HW: Phase‐Changeable Nanoemulsions for Oral Delivery of a Therapeutic Peptide: Toward Targeting the Pancreas for Antidiabetic Treatments Using Lymphatic Transport. Advanced Functional Materials 2019:1809015.
  88. Lindberg A, Lu S, Nag S, Schou M, Liow J-S, Zoghbi SS, Frankland MP, Gladding RL, Morse CL, Takano A: Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT1B receptors. Nuclear medicine and biology 2019, 70:1-13.
  89. Liu X, Ye J, Zhang Y, Liu Q, Bai R, Yuan W, Cai D, Zheng X, Bian Y, Zhou S: Ocular Biodistribution of 89 Zr-Bevacizumab in New Zealand Rabbits Determined Using PET/MRI: A Feasibility Study. Iranian Journal of Radiology 2019, 16(2).
  90. Lobaz V, Konefał R, Pánek J, Vlk M, Kozempel J, Petřík M, Novy Z, Gurská S, Znojek P, Štěpánek P: In Situ In Vivo radiolabeling of polymer-coated hydroxyapatite nanoparticles to track their biodistribution in mice. Colloids and Surfaces B: Biointerfaces 2019.
  91. Lohith TG, Bennacef I, Vandenberghe R, Vandenbulcke M, Salinas CA, Declercq R, Reynders T, Telan-Choing NF, Riffel K, Celen S: Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles. Journal of Nuclear Medicine 2019, 60(1):107-114.
  92. Lopez-Pastor AR, Gomez-Hernandez A, Diaz-Castroverde S, Gonzalez-Aseguinolaza G, Gonzalez-Rodriguez A, Garcia G, Fernandez S, Escribano O, Benito M: Liver-specific insulin receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-induced obesity. Disease models & mechanisms 2019, 12(2):dmm036186.
  93. Lozano IH, Karch R, Bauer M, Blaickner M, Matsuda A, Wulkersdorfer B, Hacker M, Zeitlinger M, Langer O: Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography. The AAPS journal 2019, 21(4):61.
  94. Macaisa CM, Watabe T, Liu Y, Romanov V, Kanai Y, Horitsugi G, Kato H, Shimosegawa E, Hatazawa J: Preserved Cerebral Oxygen Metabolism in Astrocytic Dysfunction: A Combination Study of 15O-Gas PET with 14C-Acetate Autoradiography. Brain sciences 2019, 9(5):101.
  95. Maier FC, Schweifer A, Damaraju VL, Cass CE, Bowden GD, Ehrlichmann W, Kneilling M, Pichler BJ, Hammerschmidt F, Reischl G: 2-Nitroimidazole-Furanoside Derivatives for Hypoxia Imaging—Investigation of Nucleoside Transporter Interaction, 18F-Labeling and Preclinical PET Imaging. Pharmaceuticals 2019, 12(1):31.
  96. Maleki-Balajoo S, Rahmani F, Khosrowabadi R, Meng C, Grimmer T, Drzezga A, Zarei M, Sorg C, Tahmasian M: Decoupling of inter-regional functional connectivity and regional neural activity in Alzheimer Disease. bioRxiv 2019:642629.
  97. Mannheim JG, Mamach M, Reder S, Traxl A, Mucha N, Disselhorst JA, Mittelhäuser M, Kuntner C, Thackeray JT, Ziegler S: Reproducibility and comparability of preclinical PET imaging data: A multi-center small animal PET study. Journal of Nuclear Medicine 2019:jnumed. 118.221994.
  98. Manos-Turvey A, Becker G, Francotte P, Serrano ME, Luxen A, Pirotte B, Plenevaux A, Lemaire C: Fully automated synthesis and evaluation of [18F] BPAM121: Potential of an AMPA receptor positive allosteric modulator as PET radiotracer. ChemMedChem 2019.
  99. Miranda A, Kang MS, Blinder S, Bouhachi R, Soucy J-P, Aliaga-Aliaga A, Massarweh G, Stroobants S, Staelens S, Rosa-Neto P: PET imaging of freely moving interacting rats. NeuroImage 2019.
  100. Møller A, Rømer Thomsen K, Brooks DJ, Mouridsen K, Blicher JU, Hansen KV, Lou HC: Attenuation of dopamine‐induced GABA release in problem gamblers. Brain and behavior 2019:e01239.
  101. Müller-Vahl K, Szejko N, Wilke F, Jakubovski E, Geworski L, Bengel F, Berding G: Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder. Scientific reports 2019, 9(1):972.
  102. Nack A, Brendel M, Nedelcu J, Daerr M, Nyamoya S, Beyer C, Focke C, Deussing M, Hoornaert C, Ponsaerts P: Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models. Cells 2019, 8(2):94.
  103. Narendran R, Tollefson S, Fasenmyer K, Paris J, Himes ML, Lopresti B, Ciccocioppo R, Mason NS: Decreased nociceptin receptors are related to resilience and recovery in college women who have experienced sexual violence: therapeutic implications for posttraumatic stress disorder. Biological psychiatry 2019.
  104. Nicolas CT, Hickey RD, Allen KL, Du Z, VanLith CJ, Guthman RM, Amiot B, Suksanpaisan L, Han B, Francipane MG: Ectopic hepatocyte transplantation cures the pig model of tyrosinemia. bioRxiv 2019:648493.
  105. Nikolaus S, Wittsack H-J, Beu M, Antke C, Hautzel H, Wickrath F, Müller-Lutz A, Silva MADS, Huston JP, Antoch G: Amantadine enhances nigrostriatal and mesolimbic dopamine function in the rat brain in relation to motor and exploratory activity. Pharmacology Biochemistry and Behavior 2019.
  106. No H-J, Yi H-A, Won KS, Chang HW, Kim HW: Association between white matter lesions and cerebral glucose metabolism in patients with cognitive impairment. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2019.
  107. Orteca G, Pisaneschi F, Rubagotti S, Liu TW, Biagiotti G, Piwnica-Worms D, Iori M, Capponi PC, Ferrari E, Asti M: Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies. Molecules 2019, 24(3):644.
  108. Ottoy J, Niemantsverdriet E, Verhaeghe J, De Roeck E, Struyfs H, Somers C, Wyffels L, Ceyssens S, Van Mossevelde S, Van den Bossche T: Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid-and 18F-FDG-PET imaging. NeuroImage: Clinical 2019:101771.
  109. Overgaard MD, Duvald CS, Vendelbo MH, Pedersen SB, Jakobsen S, Alstrup AKO, Mikkelsen E, Ovesen PG, Pedersen M: Biodistribution of [11C]-Metformin and mRNA Expression of Placentae Metformin Transporters in the Pregnant Chinchilla. Contrast Media & Molecular Imaging 2019, 2019.
  110. Pak K, Kim H, Seok JW, Lee MJ, Shin S, Kim K, Lee JM, Seo Y, Kim BS, Jun S: Prediction of future weight change with dopamine transporter in patients with Parkinson’s disease. Journal of Neural Transmission 2019:1-7.
  111. Palard-Novello X, Beuzit L, Gambarota G, Le Jeune F, Garin E, Salaün P-Y, Devillers A, Querellou S, Bourguet P, Saint-Jalmes H: Comparison of 18 F-Choline PET/CT and MRI functional parameters in prostate cancer. Annals of nuclear medicine 2019, 33(1):47-54.
  112. Pang H-H, Chen P-Y, Wei K-C, Huang C-W, Shiue Y-L, Huang C-Y, Yang H-W: Convection-Enhanced Delivery of a Virus-Like Nanotherapeutic Agent with Dual-Modal Imaging for Besiegement and Eradication of Brain Tumors. Theranostics 2019, 9(6):1752.
  113. Paranjpe MD, Chen X, Liu M, Paranjpe I, Leal JP, Wang R, Pomper MG, Wong DF, Benzinger TL, Zhou Y: The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study. NeuroImage: Clinical 2019, 22.
  114. Paranjpe MD, Chen X, Liu M, Paranjpe I, Leal JP, Wong R, Pomper MG, Wong DF, Benzinger TL, Zhou Y: Quantitative FDG-PET imaging of the effects of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment. NeuroImage: Clinical 2019:101795.
  115. Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M, Ghasemigharagoz A, Katzmarski N: Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nature neuroscience 2019, 22(2):191.
  116. Park H, Kim HS, Hong YJ, Min J-J, Kim HB, Kim MC, Sim DS, Kim JH, Kim D-Y, Lee JS: Therapeutic Effect of Fimasartan in a Rat Model of Myocardial Infarction Evaluated by Cardiac Positron Emission Tomography with [18F] FPTP. Chonnam Medical Journal 2019, 55(2):109-115.
  117. Paul S, Haskali MB, Liow J-S, Zoghbi SS, Barth VN, Kolodrubetz MC, Bond MR, Morse CL, Gladding RL, Frankland MP: Evaluation of a PET Radioligand to Image O-GlcNAcase in Brain and Periphery of Rhesus Monkey and Knock-Out Mouse. Journal of Nuclear Medicine 2019, 60(1):129-134.
  118. Peng S-L, Chiu H, Wu C-Y, Huang C-W, Chung Y-H, Shih C-T, Shen W-C: The effect of caffeine on cerebral metabolism during alpha-chloralose anesthesia differs from isoflurane anesthesia in the rat brain. Psychopharmacology 2019:1-9.
  119. Peretti DE, García DV, Reesink FE, van der Goot T, De Deyn PP, de Jong BM, Dierckx RA, Boellaard R: Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer’s disease PET studies. PloS one 2019, 14(1):e0211000.
  120. Philippe C, Zeilinger M, Dumanic M, Pichler F, Fetty L, Vraka C, Balber T, Wadsak W, Pallitsch K, Spreitzer H: SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [18 F] FE@ SNAP and [11 C] SNAP-7941. Molecular Imaging and Biology 2019, 21(2):257-268.
  121. Ponto LLB, Moser DJ, Menda Y, Harlynn EL, DeVries SD, Oleson JJ, Magnotta VA, Schultz SK: Early Phase PIB-PET as a Surrogate for Global and Regional Cerebral Blood Flow Measures. J Neuroimaging 2019, 29(1):85-96.
  122. Qiao L, Fisher E, McMurray L, Milicevic Sephton S, Hird M, Kuzhuppilly-Ramakrishnan N, Williamson DJ, Zhou X, Werry E, Kassiou M: Radiosynthesis of (R, S)‐[18F] GE387: A Potential PET Radiotracer for Imaging Translocator Protein 18 kDa (TSPO) with low binding sensitivity to the human gene polymorphism rs6971. ChemMedChem 2019.
  123. Quevenco F, Schreiner S, Preti M, van Bergen J, Kirchner T, Wyss M, Steininger S, Gietl A, Leh S, Buck A: GABA and glutamate moderate beta-amyloid related functional connectivity in cognitively unimpaired old-aged adults. NeuroImage: Clinical 2019:101776.
  124. Reisinger SN, Wanek T, Langer O, Pollak DD: PET imaging of the mouse brain reveals a dynamic regulation of SERT density in a chronic stress model. Translational psychiatry 2019, 9(1):80.
  125. Rezaei A, Schramm G, Willekens SM, Delso G, Van Laere K, Nuyts J: A Quantitative Evaluation of Joint Activity and Attenuation Reconstruction in TOF-PET/MR Brain Imaging. Journal of Nuclear Medicine 2019:jnumed. 118.220871.
  126. Rivera-Marrero S, Fernández-Maza L, León-Chaviano S, Sablón-Carrazana M, Bencomo-Martínez A, Perera-Pintado A, Prats-Capote A, Zoppolo F, Kreimerman I, Pardo T: [18F] Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations. Current radiopharmaceuticals 2019, 12(1):58-71.
  127. Román M, López I, Guruceaga E, Baraibar I, Ecay M, Collantes M, Nadal E, Vallejo A, Cadenas S, Echavarri-de Miguel M: Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network. Cancer research 2019, 79(3):625-638.
  128. Rosestedt M, Andersson KG, Rinne SS, Leitao CD, Mitran B, Vorobyeva A, Ståhl S, Löfblom J, Tolmachev V, Orlova A: Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake. Scientific reports 2019, 9(1):6779.
  129. Rubinstein E, Salhov M, Nidam-Leshem M, White V, Golan S, Baniel J, Bernstine H, Groshar D, Averbuch A: Unsupervised tumor detection in Dynamic PET/CT imaging of the prostate. Medical image analysis 2019, 55:27-40.
  130. Sachpekidis C, Kopp-Schneider A, Hakim-Meibodi L, Dimitrakopoulou-Strauss A, Hassel JC: 18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab. Melanoma research 2019, 29(2):178-186.
  131. Sakai K, Passioura T, Sato H, Ito K, Furuhashi H, Umitsu M, Takagi J, Kato Y, Mukai H, Warashina S: Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor. Nature chemical biology 2019, 15(6):598.
  132. Salerno M, Ferrer E, Wei S, Li X, Gao W, Ouellette D, Balanoff A, Vaska P: Behavioral neuroimaging in birds using PET. Journal of neuroscience methods 2019, 317:157-164.
  133. Sandiego CM, Barret O, Lee H, Alagille D, Amenta A, Fowles K, Holden D, Seibyl JP, Tamagnan G: Imaging Histamine H3 receptors with [18F] FMH 3: Test‐retest and occupancy studies in the non‐human primate. Synapse 2019.
  134. Schiller F, Frings L, Thurow J, Meyer PT, Mix M: Limits for reduction of acquisition time or administered activity in 18F-FDG PET studies in Alzheimer’s and frontotemporal dementia. Journal of Nuclear Medicine 2019:jnumed. 119.227132.
  135. Serrano ME, Becker G, Bahri MA, Seret A, Mestdagh N, Mercier J, Mievis F, Giacomelli F, Lemaire C, Salmon E: Evaluating the In Vivo Specificity of [18F] UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET. Molecules 2019, 24(9):1705.
  136. Shin S, Kim K, Lee JM, Kim E-J, Kim S-J, Kim IJ, Pak K, Lee MJ: Effect of Single-Nucleotide Polymorphisms on Decline of Dopamine Transporter Availability in Parkinson’s Disease. Journal of Clinical Neurology 2019, 15(1):102-107.
  137. Socan A, Petrik M, Peitl PK, Krošelj M, Rangger C, Novy Z, Svajger U, Gmeiner T, Decristoforo C: Novel cell labelling method for PET. Nuclear Medicine and Biology 2019.
  138. Spagnolo PA, Kimes A, Schwandt ML, Shokri-Kojori E, Thada S, Phillips KA, Diazgranados N, Preston KL, Herscovitch P, Tomasi D: Striatal Dopamine Release in response to Morphine: a [11C]-raclopride positron emission tomography study in Healthy Men. Biological Psychiatry 2019.
  139. Sridharan S, Raffel J, Nandoskar A, Record C, Brooks DJ, Owen D, Sharp D, Muraro PA, Gunn R, Nicholas R: Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18 F] GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter. Molecular Imaging and Biology 2019:1-10.
  140. Stenzel J, Rühlmann C, Lindner T, Polei S, Teipel S, Kurth J, Rominger A, Krause B, Vollmar B, Kuhla A: [18F]-florbetaben PET/CT Imaging in the Alzheimer’s Disease Mouse Model APPswe/PS1dE9. Current Alzheimer Research 2019, 16(1):49-55.
  141. Stieb S, Riesterer O, Boss A, Weiss T, Guckenberger M, Özbay PS, Nanz D, Rossi C: Dependency of the blood oxygen level dependent-response to hyperoxic challenges on the order of gas administration in intracranial malignancies. Neuroradiology 2019:1-11.
  142. Sugyo A, Aung W, Tsuji AB, Sudo H, Takashima H, Yasunaga M, Matsumura Y, Saga T, Higashi T: Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic cancer. Oncology reports 2019, 41(4):2371-2378.
  143. Svoboda J, Litvinec A, Kala D, Pošusta A, Vávrová L, Jiruška P, Otáhal J: Strain Differences in Intraluminal Thread Model of Middle Cerebral Artery Occlusion in Rats. Physiological research 2019, 68(1):37-48.
  144. Tai YC, Chi MH, Chu C-L, Chiu NT, Yao WJ, Chen PS, Yang YK: Availability of striatal dopamine transporter in healthy individuals with and without a family history of ADHD. Journal of attention disorders 2019, 23(7):665-670.
  145. Takamura Y, Shibahara O, Watanabe M, Fujihara M, Yamada S, Akehi M, Sasaki T, Hirano H, Kakuta H: Fluorine-18 (18F)-labeled Retinoid X Receptor (RXR) Partial Agonist whose Tissue Transferability is Affected by Other RXR Ligands. Bioorganic & Medicinal Chemistry 2019.
  146. Takeuchi J, Kikukawa T, Saito H, Hasegawa I, Takeda A, Hatsuta H, Kawabe J, Wada Y, Mawatari A, Igesaka A: Amyloid-Negative Dementia in the Elderly is Associated with High Accumulation of Tau in the Temporal Lobes. The Open Biomedical Engineering Journal 2019, 13(1).
  147. Terada T, Yokokura M, Obi T, Bunai T, Yoshikawa E, Ando I, Shimada H, Suhara T, Higuchi M, Ouchi Y: In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease. Journal of neurology 2019:1-11.
  148. Thapa N, Jeong Y-J, Kang H, Choi G-E, Yoon H-J, Kang D-Y: A Comparative Study of [F-18] Florbetaben (FBB) PET Imaging, Pathology, and Cognition between Normal and Alzheimer Transgenic Mice. Biomedical Science Letters 2019, 25(1):7-14.
  149. Thonglim P, Chotipanich C, Iamsa-art C, Jantarato A, Buranasiri P: Surface of quantitative uptake value of radiopharmaceutical PET/CT in normal Thai population. In: Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XVII: 2019: International Society for Optics and Photonics; 2019: 108681I.
  150. Tible M, Mouton Liger F, Schmitt J, Giralt A, Farid K, Thomasseau S, Gourmaud S, Paquet C, Rondi Reig L, Meurs E: PKR knockout in the 5xFAD model of Alzheimer’s disease reveals beneficial effects on spatial memory and brain lesions. Aging cell 2019:e12887.
  151. Tiepolt S, Luthardt J, Patt M, Hesse S, Hoffmann KT, Weise D, Gertz HJ, Barthel H: Early after Administration [11C] PiB PET Images Correlate with Cognitive Dysfunction Measured by the CERAD Test Battery. Journal of Alzheimer’s Disease 2019(Preprint):1-12.
  152. Tobon G, Hesterman J, Patel S, Lackas C: High-Level Story: Data Analysis in Multimodal Preclinical Imaging—Methods and Tools. In: Image Fusion in Preclinical Applications. edn.: Springer; 2019: 1-24.
  153. Tollefson S, Gertler J, Himes ML, Paris J, Kendro S, Lopresti B, Scott Mason N, Narendran R: Imaging phosphodiesterase‐10a availability in cocaine use disorder with [11C] IMA107 and PET. Synapse 2019, 73(1):e22070.
  154. Tomadesso C, Gonneaud J, Egret S, Perrotin A, Pélerin A, de Flores R, de la Sayette V, Desgranges B, Chételat G, La Joie R: Is there a specific memory signature associated with Aβ-PET positivity in patients with amnestic mild cognitive impairment? Neurobiology of aging 2019, 77:94-103.
  155. Tool K: Positron Emission Tomography. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development 2019:191.
  156. Tournier N, Bauer M, Pichler V, Nics L, Klebermass E-M, Bamminger K, Matzneller P, Weber M, Karch R, Caille F: Impact of P-glycoprotein Function on the Brain Kinetics of the Weak Substrate 11C-Metoclopramide Assessed with PET Imaging in Humans. Journal of Nuclear Medicine 2019:jnumed. 118.219972.
  157. Truong VA, Hsu M-N, Nguyen K, Thi N, Lin M-W, Shen C-C, Lin C-Y, Hu Y-C: CRISPRai for simultaneous gene activation and inhibition to promote stem cell chondrogenesis and calvarial bone regeneration. Nucleic acids research 2019.
  158. Tsai H-H, Pasi M, Tsai L-K, Chen Y-F, Lee B-C, Tang S-C, Fotiadis P, Huang C-Y, Yen R-F, Jeng J-S: Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: A PiB-PET study. Neurology 2019, 92(8):e774-e781.
  159. Tseng J-R, Chang Y-H, Yang L-Y, Wu C-T, Chen S-Y, Wan C-H, Hsiao T, Yen T-C: Potential usefulness of 68 Ga-citrate PET/CT in detecting infected lower limb prostheses. EJNMMI research 2019, 9(1):2.
  160. Tsukada H: PET Imaging of Mitochondrial Function in the Living Brain. In: Mitochondrial and Brain Disorders. edn.: IntechOpen; 2019.
  161. Tuura ROG, Warnock G, Ametamey S, Treyer V, Noeske R, Buck A, Sommerauer M: Imaging glutamate redistribution after acute N-acetylcysteine administration: A simultaneous PET/MR study. NeuroImage 2019, 184:826-833.
  162. Unterrainer M, Fleischmann D, Diekmann C, Vomacka L, Lindner S, Vettermann F, Brendel M, Wenter V, Ertl-Wagner B, Herms J: Comparison of 18 F-GE-180 and dynamic 18 F-FET PET in high grade glioma: a double-tracer pilot study. European journal of nuclear medicine and molecular imaging 2019, 46(3):580-590.
  163. Vainio S, Dickens A, Tuisku J, Eskola O, Solin O, Löyttyniemi E, Anthony D, Rinne J, Airas L, Haaparanta-Solin M: Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation. EJNMMI research 2019, 9(1):38.
  164. Valli M, Cho SS, Masellis M, Chen R, Rusjan P, Kim J, Koshimori Y, Mihaescu A, Strafella AP: DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum. Molecular neurobiology 2019:1-9.
  165. Vandergaast R, Khongwichit S, Jiang H, DeGrado TR, Peng K-W, Smith DR, Russell SJ, Suksanpaisan L: Enhanced noninvasive imaging of oncology models using the NIS reporter gene and bioluminescence imaging. Cancer gene therapy 2019:1.
  166. Verhoeven J, Hulpia F, Kersemans K, Bolcaen J, De Lombaerde S, Goeman J, Descamps B, Hallaert G, Van den Broecke C, Deblaere K: New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma. Scientific reports 2019, 9(1):2878.
  167. Vlachavas EI, Pilalis E, Papadodima O, Koczan D, Willis S, Klippel S, Cheng C, Pan L, Sachpekidis C, Pintzas A: Radiogenomic Analysis of F-18-Fluorodeoxyglucose Positron Emission Tomography and Gene Expression Data Elucidates the Epidemiological Complexity of Colorectal Cancer Landscape. Computational and structural biotechnology journal 2019, 17:177-185.
  168. von Witting E, Garousi J, Lindbo S, Vorobyeva A, Altai M, Oroujeni M, Mitran B, Orlova A, Hober S, Tolmachev V: Selection of the optimal macrocyclic chelators for labeling with 111In and 68Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6. European Journal of Pharmaceutics and Biopharmaceutics 2019.
  169. Vrselja Z, Daniele SG, Silbereis J, Talpo F, Morozov YM, Sousa AM, Tanaka BS, Skarica M, Pletikos M, Kaur N: Restoration of brain circulation and cellular functions hours post-mortem. Nature 2019, 568(7752):336.
  170. Wagner JM, Sichler ME, Schleicher EM, Franke TN, Irwin C, Löw MJ, Beindorff N, Bouter C, Bayer TA, Bouter Y: Analysis of motor function in the Tg4-42 mouse model of Alzheimer’s disease. Frontiers in Behavioral Neuroscience 2019, 13:107.
  171. Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR: Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nature medicine 2019, 25(1):141.
  172. Weiskirchen R, Weiskirchen S, Kim P, Winkler R: Software solutions for evaluation and visualization of laser ablation inductively coupled plasma mass spectrometry imaging (LA-ICP-MSI) data: a short overview. Journal of cheminformatics 2019, 11(1):16.
  173. Wolf F, Paefgen V, Winz O, Mertens M, Koch S, Gross-Weege N, Morgenroth A, Rix A, Schnoering H, Chalabi K: MR and PET-CT monitoring of tissue-engineered vascular grafts in the ovine carotid artery. Biomaterials 2019:119228.
  174. Xiong C, Yin D, Li J, Huang Q, Ravoori MK, Kundra V, Zhu H, Yang Z, Lu Y, Li C: Metformin Reduces Renal Uptake of Radiotracers and Protects Kidneys from Radiation-Induced Damage. Molecular pharmaceutics 2019, 16(2):808-815.
  175. Xu J-G: Evaluation of Neuropathic Pain in a Rat Model of Total Brachial Plexus Avulsion from Behavior to Brain Metabolism. Pain Physician 2019, 22:E215-E224.
  176. Yang M, Kong DY, Chen JC: Inhibition of miR‐148b ameliorates myocardial ischemia/reperfusion injury via regulation of Wnt/β‐catenin signaling pathway. Journal of cellular physiology 2019.
  177. Yin L, Sun H, Zhao M, Wang A, Qiu S, Gao Y, Ding J, Ji S-J, Shi H, Gao M: Rational Design and Synthesis of a Metalloproteinase-Activatable Probe for Dual-Modality Imaging of Metastatic Lymph Nodes in Vivo. The Journal of organic chemistry 2019.
  178. Zhao YH, Liu NW, Ke CC, Liu BW, Chen YA, Luo C, Zhang Q, Xia ZY, Liu RS: Combined treatment of sodium ferulate, n‐butylidenephthalide, and ADSC s rehabilitates neurovascular unit in rats after photothrombotic stroke. Journal of cellular and molecular medicine 2019, 23(1):126-142.
  179. Zorick T, Okita K, Mandelkern MA, London ED, Brody AL: Effects of Citalopram on Cue-induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability. International Journal of Neuropsychopharmacology 2019, 22(4):286-291.